Cavo, Michele; Terpos, Evangelos; Nanni, Cristina; Moreau, Philippe; Lentzsch, Suzanne; Zweegman, Sonja; Hillengass, Jens; Engelhardt, Monika; Usmani, Saad Z; Vesole, David H; San-Miguel, Jesus; Kumar, Shaji K; Richardson, Paul G; Mikhael, Joseph R; da Costa, Fernando Leal; Dimopoulos, Meletios-Athanassios; Zingaretti, Chiara; Abildgaard, Niels; Goldschmidt, Hartmut; Orlowski, Robert Z; Chng, Wee Joo; Einsele, Hermann; Lonial, Sagar; Barlogie, Bart; Anderson, Kenneth C; Rajkumar, S Vincent; Durie, Brian G M; Zamagni, Elena, Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group, «THE LANCET ONCOLOGY», 2017, 18, pp. e206 - e217 [articolo]
Anderson, Kenneth C; Auclair, Daniel; Kelloff, Gary J; Sigman, Caroline C; Avet-Loiseau, Herve; Farrell, Ann T; Gormley, Nicole J; Kumar, Shaji K; Landgren, Ola; Munshi, Nikhil C; Cavo, Michele; Davies, Faith E; Di Bacco, Alessandra; Dickey, Jennifer S; Gutman, Steven I; Higley, Howard R; Hussein, Mohamad A; Jessup, J Milburn; Kirsch, Ilan R; Little, Richard F; Loberg, Robert D; Lohr, Jens G; Mukundan, Lata; Omel, James L; Pugh, Trevor J; Reaman, Gregory H; Robbins, Michael D; Sasser, A Kate; Valente, Nancy; Zamagni, Elena, The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications, «CLINICAL CANCER RESEARCH», 2017, 23, pp. 3980 - 3993 [articolo]
Nanni, Cristina; Zamagni, Elena, Therapy assessment in multiple myeloma with PET, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2017, 44, pp. 111 - 117 [articolo]
Zamagni, Elena; Cavo, Michele, Toward a GEP-based PET in myeloma, «BLOOD», 2017, 130, pp. 2 - 3 [articolo]
Pantani, L; Brioli, A; Tacchetti, P; Zannetti, B A; Mancuso, K; Rocchi, Serena; Martello, M; Rizzello, I; Terragna, C; Zamagni, E; Cavo, M, Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma, «EXPERT REVIEW OF HEMATOLOGY», 2016, 9, pp. 315 - 323 [articolo]Open Access
Nanni, Cristina; Zamagni, Elena; Versari, Annibale; Chauvie, Stephane; Bianchi, Andrea; Rensi, Marco; Bellò, Marilena; Rambaldi, Ilaria; Gallamini, Andrea; Patriarca, Francesca; Gay, Francesca; Gamberi, Barbara; Cavo, Michele; Fanti, Stefano, Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe), «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2016, 43, pp. 414 - 421 [articolo]
Kumar, Shaji; Paiva, Bruno; Anderson, Kenneth C; Durie, Brian; Landgren, Ola; Moreau, Philippe; Munshi, Nikhil; Lonial, Sagar; Bladé, Joan; Mateos, Maria Victoria; Dimopoulos, Meletios; Kastritis, Efstathios; Boccadoro, Mario; Orlowski, Robert; Goldschmidt, Hartmut; Spencer, Andrew; Hou, Jian; Chng, Wee Joo; Usmani, Saad Z; Zamagni, Elena; Shimizu, Kazuyuki; Jagannath, Sundar; Johnsen, Hans E; Terpos, Evangelos; Reiman, Anthony; Kyle, Robert A; Sonneveld, Pieter; Richardson, Paul G; Mccarthy, Philip; Ludwig, Heinz; Chen, Wenming; Cavo, Michele; Harousseau, Jean Luc; Lentzsch, Suzanne; Hillengass, Jens; Palumbo, Antonio; Orfao, Alberto; Rajkumar, S. Vincent; Miguel, Jesus San; Avet Loiseau, Herve, International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma, «THE LANCET ONCOLOGY», 2016, 17, pp. e328 - e346 [articolo]
Pezzi, Annalisa; Cavo, Michele; Biggeri, Annibale; Zamagni, Elena; Nanni, Oriana, Inverse probability weighting to estimate causal effect of a singular phase in a multiphase randomized clinical trial for multiple myeloma, «BMC MEDICAL RESEARCH METHODOLOGY», 2016, 16, Article number: 150, pp. 1 - 10 [articolo]Open Access
Laubach, J; Garderet, L.; Mahindra, A.; Gahrton, G.; Caers, J.; Sezer, O.; Voorhees, P.; Leleu, X.; Johnsen, H. E.; Streetly, M.; Jurczyszyn, A.; Ludwig, H.; Mellqvist, U. H.; Chng, W. J.; Pilarski, L.; Einsele, H.; Hou, J.; Turesson, I.; Zamagni, Elena; Chim, C. S.; Mazumder, A.; Westin, J.; Lu, Jiachuan; Reiman, T.; Kristinsson, S.; Joshua, D.; Roussel, M.; O'Gorman, P.; Terpos, E.; Mccarthy, P.; Dimopoulos, M.; Moreau, Philippe; Orlowski, R. Z.; Miguel, J. S.; Anderson, K. C.; Palumbo, A.; Kumar, S.; Rajkumar, V.; Durie, B.; Richardson, P. G., Management of relapsed multiple myeloma: Recommendations of the International Myeloma Working Group, «LEUKEMIA», 2016, 30, pp. 1005 - 1017 [articolo]
Zamagni, Elena; Tacchetti, Paola; Terragna, Carolina; Cavo, Michele, Multiple myeloma: disease response assessment, «EXPERT REVIEW OF HEMATOLOGY», 2016, 9, pp. 831 - 837 [articolo]
Martello, Marina; Remondini, Daniel; Borsi, Enrica; Santacroce, Barbara; Procacci, M.; Pezzi, Annalisa; Dico, F. A.; Martinelli, Giovanni; Zamagni, Elena; Tacchetti, Paola; Pantani, Lucia; Testoni, Nicoletta; Marzocchi, Giulia; Rocchi, Serena; Zannetti, BEATRICE ANNA; Mancuso, Katia; Cavo, Michele; Terragna, Carolina, Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis, «LEUKEMIA», 2016, 30, pp. 1869 - 1876 [articolo]
Tacchetti, Paola; Cavo, Michele; Rocchi, Serena; Pezzi, Annalisa; Pantani, Lucia; Brioli, Annamaria; Testoni, Nicoletta; Terragna, Carolina; Zannetti, BEATRICE ANNA; Mancuso, Katia; Marzocchi, Giulia; Borsi, Enrica; Martello, Marina; Rizzello, Ilaria; Zamagni, Elena, Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens, «LEUKEMIA & LYMPHOMA», 2016, 57(9), pp. 2058 - 2064 [articolo]
Terragna, Carolina; Remondini, Daniel; Martello, Marina; Zamagni, Elena; Pantani, Lucia; Patriarca, Francesca; Pezzi, Annalisa; Levi, Giuseppe; Offidani, Massimo; Proserpio, Ilaria; De Sabbata, Giovanni; Tacchetti, Paola; Cangialosi, Clotilde; Ciambelli, Fabrizio; Viganò, Clara Virginia; Dico, Flores Angela; Santacroce, Barbara; Borsi, Enrica; Brioli, Annamaria; Marzocchi, Giulia; Castellani, Gastone; Martinelli, Giovanni; Palumbo, Antonio; Cavo, Michele, The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD), «ONCOTARGET», 2016, 7, pp. 9666 - 9679 [articolo]
Zamagni, E; Nanni, C; Gay, F; Pezzi, A; Patriarca, F; Bellò, M; Rambaldi, I; Tacchetti, P; Hillengass, J; Gamberi, B; Pantani, L; Magarotto, V; Versari, A; Offidani, M; Zannetti, B; Carobolante, F; Balma, M; Musto, P; Rensi, M; Mancuso, K; Dimitrakopoulou-Strauss, A; Chauviè, S; Rocchi, Serena; Fard, N; Marzocchi, G; Storto, G; Ghedini, P; Palumbo, A; Fanti, S; Cavo, M, 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease, «LEUKEMIA», 2016, 30, pp. 417 - 422 [articolo]Open Access
Zannetti, Beatrice Anna; Zamagni, Elena; Santostefano, Marisa; De Sanctis, Lucia Barbara; Tacchetti, Paola; Mancini, Elena; Pantani, Lucia; Brioli, Annamaria; Rizzo, Raffaella; Mancuso, Katia; Rocchi, Serena; Pezzi, Annalisa; Borsi, Enrica; Terragna, Carolina; Marzocchi, Giulia; Santoro, Antonio; Cavo, Michele, Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment, «AMERICAN JOURNAL OF HEMATOLOGY», 2015, 90, pp. 647 - 652 [articolo]
